Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Acquisitions (2023 - 2024)

Historic Acquisitions for Cytek Biosciences (CTKB) over the last 2 years, with Q4 2024 value amounting to $471000.0.

  • Cytek Biosciences' Acquisitions changed N/A to $471000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $471000.0, marking a year-over-year decrease of 9895.09%. This contributed to the annual value of $471000.0 for FY2024, which is 9895.09% down from last year.
  • Cytek Biosciences' Acquisitions amounted to $471000.0 in Q4 2024.
  • Over the past 5 years, Cytek Biosciences' Acquisitions peaked at $44.9 million during Q1 2023, and registered a low of $1000.0 during Q3 2023.